Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Interleukin-22: a potential immunomodulatory molecule in the lung.

Whittington HA, Armstrong L, Uppington KM, Millar AB.

Am J Respir Cell Mol Biol. 2004 Aug;31(2):220-6.

PMID:
15039135
2.

Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.

Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R.

Int Immunopharmacol. 2004 May;4(5):679-91.

PMID:
15120652
3.

Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages.

Lim S, Caramori G, Tomita K, Jazrawi E, Oates T, Chung KF, Barnes PJ, Adcock IM.

Allergy. 2004 May;59(5):505-14.

4.

Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.

Bost TW, Riches DW, Schumacher B, Carré PC, Khan TZ, Martinez JA, Newman LS.

Am J Respir Cell Mol Biol. 1994 May;10(5):506-13.

PMID:
8179912
5.

Interleukin-10 induces uteroglobin-related protein (UGRP) 1 gene expression in lung epithelial cells through homeodomain transcription factor T/EBP/NKX2.1.

Srisodsai A, Kurotani R, Chiba Y, Sheikh F, Young HA, Donnelly RP, Kimura S.

J Biol Chem. 2004 Dec 24;279(52):54358-68.

6.

Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung.

Hancock A, Armstrong L, Gama R, Millar A.

Am J Respir Cell Mol Biol. 1998 Jan;18(1):60-5.

PMID:
9448046
7.

Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease.

Martinez JA, King TE Jr, Brown K, Jennings CA, Borish L, Mortenson RL, Khan TZ, Bost TW, Riches DW.

Am J Physiol. 1997 Sep;273(3 Pt 1):L676-83.

PMID:
9316504
8.

Increased interleukin-13 expression in patients with sarcoidosis.

Hauber HP, Gholami D, Meyer A, Pforte A.

Thorax. 2003 Jun;58(6):519-24.

9.

Activation of the STAT3/acute phase response factor transcription factor by interleukin-5.

Caldenhoven E, van Dijk T, Raaijmakers JA, Lammers JW, Koenderman L, De Groot RP.

J Biol Chem. 1995 Oct 27;270(43):25778-84.

10.

Cloning and characterization of mouse IL-22 binding protein.

Wei CC, Ho TW, Liang WG, Chen GY, Chang MS.

Genes Immun. 2003 Apr;4(3):204-11.

PMID:
12700595
11.

Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.

Chada S, Mhashilkar AM, Ramesh R, Mumm JB, Sutton RB, Bocangel D, Zheng M, Grimm EA, Ekmekcioglu S.

Mol Ther. 2004 Dec;10(6):1085-95.

12.

Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.

Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.

Rheumatology (Oxford). 2005 Aug;44(8):983-8.

13.

Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13.

Faffe DS, Flynt L, Mellema M, Moore PE, Silverman ES, Subramaniam V, Jones MR, Mizgerd JP, Whitehead T, Imrich A, Panettieri RA Jr, Shore SA.

J Allergy Clin Immunol. 2005 Mar;115(3):514-20.

PMID:
15753898
14.

Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.

Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, Nojima Y.

Arthritis Rheum. 2005 Apr;52(4):1037-46.

15.

Impaired induction of IL-10 expression in the lung following hemorrhagic shock.

Khadaroo RG, Fan J, Powers KA, Fann B, Kapus A, Rotstein OD.

Shock. 2004 Oct;22(4):333-9.

PMID:
15377888
16.

Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.

Fernandez S, Jose P, Avdiushko MG, Kaplan AM, Cohen DA.

J Immunol. 2004 Feb 15;172(4):2613-20.

17.

Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.

Oltmanns U, Schmidt B, Hoernig S, Witt C, John M.

Exp Lung Res. 2003 Jul;29(5):315-28.

PMID:
12746045
19.

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity.

Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S.

J Immunol. 2001 Jun 15;166(12):7096-103.

20.

IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.

Baird AM, Gray SG, O'Byrne KJ.

Eur J Cancer. 2011 Aug;47(12):1908-18. doi: 10.1016/j.ejca.2011.04.012.

PMID:
21565488
Items per page

Supplemental Content

Support Center